Sg3 Management, LLC Immuno Gen, Inc. Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.75 - $7.5 $118,750 - $187,500	-25,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $82,830 - $108,735	16,500 Added 194.12%	25,000 $142,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $49,215 - $73,100	8,500 New	8,500 $56,000
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $33,200 - $53,400	-10,000 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.12 - $6.8 $21,200 - $68,000	10,000 New	10,000 $34,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.